O15-Water

4 trials 2 recruiting

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

1 Completed trials

4 Sponsors

5 Countries

Phase III

Phase I (Other)

Phase III: 3 Phase I (Other): 1

Indications tested

Heart failure with reduced ejection fraction 1 Renal impairment 1

Sponsors using this IMP

AstraZeneca AB 1 MedTrace Pharma A/S 1 Oslo University Hospital HF 1 Vaestra Goetalandsregionen 1

All trials

4 total

Prognostic Performance of Quantitative Myocardial Perfusion Imaging Using H2[15O] Positron Emission Tomography in Coronary Artery Disease - … Pending

2024-518706-41-01 Phase III 1 country Vaestra Goetalandsregionen
Water absorption in brain of hydrocephalus Recruiting

2024-519933-53-00 Phase III 1 country Oslo University Hospital HF
A Phase 3, Multicenter, Open Label Study to Confirm the Diagnostic Potential of Intravenously Administered 15O- H2O to Identify Coronary Art… Recruiting

2023-503843-33-00 Phase III 4 countries MedTrace Pharma A/S
A Phase 1b, Double-blind, Placebo-controlled, Randomised Trial Investigating the Effect of AZD3427 on Renal Perfusion in HFrEF Patients With… Ended

2024-513143-82-00 Phase I (Other) 1 country AstraZeneca AB

Showing 1–4 of 4 trials

← All drugs A–Z